Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.
about
Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestryAnnual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Novel therapeutic strategies for patients with triple-negative breast cancerUS incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanksExtracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro.Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomasPrevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis.Distinct breast cancer subtypes in women with early-onset disease across racesSorting reality from what we think we know about breast cancer in Africa.There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population.Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010Basal-like and triple-negative breast cancers: searching for positives among many negativesTriple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review.Epigenetics in breast and prostate cancerClinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experienceBiologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.Psychosocial concerns of young African American breast cancer survivorsThe Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.Socioeconomic status and incidence of breast cancer by hormone receptor subtype.Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients.Occurrence of breast cancer subtypes in adolescent and young adult women.Clinical implications of molecular heterogeneity in triple negative breast cancer.Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.Epidemiology of triple negative breast cancersMammography Adherence in African-American Women: Results of a Randomized Controlled TrialBreed- and age-related differences in canine mammary tumorsPopulation and target considerations for triple-negative breast cancer clinical trials.Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.Connecting communities to health research: development of the Project CONNECT minority research registry.Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
P2860
Q27011535-BB30E4E9-DA20-4CDA-956B-5394F5CD6321Q27300459-5CDBC7D1-6FA0-4BDC-BE10-407E01EBA25AQ28067436-1B68681E-4CD1-4B1A-92B0-4CC743A589BAQ30665329-B6AB093A-B311-4177-8599-3B6D7E23BC62Q31102636-09C0F8B7-CDE7-42CE-AEEF-2013E4AD04D8Q31111254-254F47AB-E679-4A98-B18C-DA1778024B45Q33591876-CEF2F222-E911-4153-A912-7A9356C5EF0BQ33632534-ACB03E93-33C5-4118-BC0B-5DAE3822CFE4Q33634352-69CE05CB-7DD0-485F-9719-38BFC5CD4ABEQ33787201-B6BE6C5E-BDE0-4AC1-929C-9C73C49AE8FDQ33859673-35E6344E-0C4D-44E2-847E-624AC467D6C1Q33932660-2F4D9B5A-9088-4A39-9061-0143A961BBE9Q34155207-C103CEC1-30FF-48B7-BD26-0A95D3743293Q34653505-64C14021-6A65-41C3-947D-CEC73AD873A9Q35003673-E0AF279A-4ECE-4177-9D94-09C5BEE6EA16Q35005793-4929A35F-F85D-474F-88E5-BF9E6A402856Q35027892-7BEDF325-A6E7-4251-83BD-206B45DB516BQ35059135-543C1F59-3136-4951-8703-05C7CE78FD00Q35190483-8C78B552-A456-4A5E-B3CD-894221ECD72CQ35214479-4B0D5EB0-12A0-43DA-B7FC-1F00C3CAA762Q35271188-DF4C4356-0E2C-4E38-898E-EF01B4358B1DQ35593154-5BD93F2E-E31F-4B23-B217-2F016A7EC24AQ35839525-8A21B858-BA8E-4087-A519-4A594C117244Q35962877-F72399E7-C5FD-4930-A9B9-DC3C61AA4048Q36003843-0C37E7C6-47FF-4EFE-9FD5-B4D2D0D991D7Q36054418-287549F1-977D-476A-929C-6E760B3D2253Q36070107-3AC50085-66EC-46D9-AF68-7287BA663523Q36089302-2DDB3CF1-52F5-4632-8481-6669D674A957Q36245578-B1893102-5CDB-4481-8391-93028999D209Q36271396-BCEBE235-A1D1-420F-AF0E-9FC1CA818794Q36287832-FBB0806B-C409-4F0D-85C6-0FE104A1BCEAQ36365067-DA6E0305-A9ED-4D7C-99C6-2163F592BE84Q36386871-83F89404-F26A-4B5E-A012-C9C69E13BB25Q36552560-F283244A-27B0-456C-B693-C90C09B3D0A0Q36811022-CD4AC805-AF82-4C09-87DD-64AA7D0897D9Q36914317-58BCD264-F67E-4357-9635-75D7BBCA2460Q36977429-9B82BAC3-5A46-4639-ADB3-D024E82072FCQ37077443-1E4120F4-C0C1-4D84-9022-EABEA7202E78Q37191664-18796C32-36D2-4603-AD1B-FA415B97F083Q37226242-8B735F97-0413-4878-8982-9A9B43E50C44
P2860
Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Higher population-based incide ...... cer screening recommendations.
@ast
Higher population-based incide ...... cer screening recommendations.
@en
type
label
Higher population-based incide ...... cer screening recommendations.
@ast
Higher population-based incide ...... cer screening recommendations.
@en
prefLabel
Higher population-based incide ...... cer screening recommendations.
@ast
Higher population-based incide ...... cer screening recommendations.
@en
P2093
P2860
P356
P1433
P1476
Higher population-based incide ...... cer screening recommendations.
@en
P2093
Jason Bush
Kathryn C Amirikia
Lisa A Newman
Paul Mills
P2860
P304
P356
10.1002/CNCR.25862
P407
P577
2011-01-10T00:00:00Z